Trials / Completed
CompletedNCT01487590
Cephalic Version by Acupuncture-Moxibustion for Breech Presentation
A Simple Blind Controlled Randomized Trial: Cephalic Version by Acupuncture-moxibustion vs Placebo for Breech Presentation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 328 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
For breech presentation, the cesarean section rate is decreased by external cephalic version. This is a painful operation, with some rare but serious complications. The aim of this trial is to evaluate the effectiveness of acupuncture-moxibustion, a non-invasive technique, to correct breech presentation before 37 weeks of gestation.
Detailed description
Monocentric controlled randomized trial in a simple blind fashion, comparing acupuncture-moxibustion versus a placebo in singleton pregnancies with breech presentation between 33+5 to 35+5 weeks of gestation. The intervention arm consists of acupuncture-moxibustion at the BL67 acupuncture point, for six seances of twenty minutes two days apart. In the placebo group, the cold light of an inactivated laser is to be applied in the same point during the same time. When cephalic version fail, a manual external cephalic version is to be proposed. The main outcome measure is cephalic presentation at 37+2 weeks of gestation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Acupuncture moxibustion | Six interventions with acupuncture moxibustion, stimulating point BL67, during 20 minutes each, 48 hours apart. |
| OTHER | Placebo | Six interventions with placebo (inactivated laser), stimulating point BL67, during 20 minutes each, 48 hours apart |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2011-12-07
- Last updated
- 2025-12-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01487590. Inclusion in this directory is not an endorsement.